Archive - December 2021
Novartis to pay up to $1.5bn for Gyroscope
FDA rejects Takeda’s Eohilia after delays
AstraZeneca and Novavax say their vaccines are effective against Omicron
COVID-19 vaccine should be offered to vulnerable children aged five to 11-years-old
Novartis Cosentyx Receives FDA Approval for the Treatment of Children and Adolescents with Enthesitis-Related Arthritis and Psoriatic Arthritis
FDA Approves Leqvio (inclisiran), First-in-Class siRNA to Reduce Low-Density Lipoprotein Cholesterol (LDL-C)
FDA approves Amgen’s Otezla for all patients with plaque psoriasis
Sanofi to pay $1.2bn to acquire Amunix and its ‘stealth’ technology